D.E. Shaw & Co’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,028
| Closed | -$8K | – | 4332 |
|
|
2022
Q2 | $8K | Buy |
+23,028
| New | +$8K | ﹤0.01% | 3995 |
|
|
2021
Q2 | – | Sell |
-165,235
| Closed | -$431K | – | 3850 |
|
|
2021
Q1 | $431K | Buy |
+165,235
| New | +$431K | ﹤0.01% | 2548 |
|
|
2020
Q3 | – | Sell |
-161,702
| Closed | -$456K | – | 2866 |
|
|
2020
Q2 | $456K | Buy |
161,702
+66,859
| +70% | +$189K | ﹤0.01% | 2199 |
|
|
2020
Q1 | $231K | Buy |
94,843
+69,750
| +278% | +$170K | ﹤0.01% | 2412 |
|
|
2019
Q4 | $128K | Buy |
+25,093
| New | +$128K | ﹤0.01% | 2554 |
|
|
2018
Q1 | – | Sell |
-9,047
| Closed | -$381K | – | 2704 |
|
|
2017
Q4 | $381K | Sell |
9,047
-277
| -3% | -$11.7K | ﹤0.01% | 2192 |
|
|
2017
Q3 | $513K | Sell |
9,324
-201,593
| -96% | -$11.1M | ﹤0.01% | 2049 |
|
|
2017
Q2 | $39.1M | Buy |
210,917
+19,409
| +10% | +$3.6M | 0.06% | 287 |
|
|
2017
Q1 | $22.9M | Buy |
191,508
+866
| +0.5% | +$104K | 0.04% | 412 |
|
|
2016
Q4 | $18.9M | Sell |
190,642
-2,069
| -1% | -$206K | 0.03% | 477 |
|
|
2016
Q3 | $21.6M | Buy |
192,711
+975
| +0.5% | +$109K | 0.04% | 396 |
|
|
2016
Q2 | $19.7M | Buy |
191,736
+2,797
| +1% | +$287K | 0.04% | 422 |
|
|
2016
Q1 | $17.4M | Sell |
188,939
-12,323
| -6% | -$1.13M | 0.03% | 459 |
|
|
2015
Q4 | $29M | Sell |
201,262
-44,288
| -18% | -$6.39M | 0.04% | 340 |
|
|
2015
Q3 | $25.4M | Buy |
245,550
+26,800
| +12% | +$2.77M | 0.04% | 386 |
|
|
2015
Q2 | $35.7M | Buy |
+218,750
| New | +$35.7M | 0.05% | 322 |
|